ESC Professional Premium Access

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Congress Presentation

About the speaker

Doctor Howell James Williams

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Speaker: Doctor B. Wang (Galway, IE)


Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Speaker: Doctor C. Waechter (Marburg, DE)


The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Speaker: Doctor C. Paitazoglou (Luebeck, DE)


Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Speaker: Doctor E. Zancanaro (Milan, IT)


Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Speaker: Mrs M. Rivadeneira Ruiz (Madrid, ES)


Access the full session

Complex and novel interventions for heart failure

Speakers: Doctor H. Williams, Doctor B. Wang, Doctor C. Waechter, Doctor C. Paitazoglou, Doctor E. Zancanaro...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb